JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 38:1070-1077
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v39,p1408)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klatte, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klatte, K.

Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release

Results from the GUARDIAN trial

Karen Klatte, MD*, Bernard R. Chaitman, MD, FACC*,2, Pierre Theroux, MD, FACC{dagger},2, Jeffrey A. Gavard, PhD*, Karen Stocke, MBA*, Steven Boyce, MD, FACC{ddagger},2, Claus Bartels, MD§,2, Birgit Keller, MS||,2, Andreas Jessel, MD||,2 for the GUARDIAN Investigators1

* St. Louis University Health Sciences Center, St. Louis, Missouri, USA
{dagger} Montreal Heart Institute, Montreal, Quebec, Canada
{ddagger} Washington Heart Center, Washington, DC, USA
§ Med. Universitatsklinik, Herzchirurgische Klinik, Luebeck, Germany
|| Aventis Pharmaceuticals, Inc., Bridgewater, New Jersey, USA



View larger version (22K):

[in a new window]
 
Figure 1 Cumulative six-month survival rates according to the peak creatine kinase-myocardial band ratio category (p < 0.0001). All pairwise comparisons between the categories were significant, except for the ≥5 and <10 upper limits of normal (ULN) group versus the ≥10 and <20 ULN group (p = 0.26). CABG = coronary artery bypass graft surgery.

 


View larger version (20K):

[in a new window]
 
Figure 2 Cumulative six-month survival rates according to the peak creatine kinase-myocardial band value category (p < 0.0001). All pairwise comparisons between the categories were significant, except for the ≤60 U/l group versus the >60 and ≤100 U/l group (p = 0.09). CABG = coronary artery bypass graft surgery.

 


View larger version (17K):

[in a new window]
 
Figure 3 Receiver operating characteristic curve predicting six-month mortality at various levels of peak creatine kinase-myocardial band (CK-MB) enzyme ratios. ULN = upper limits of normal.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.